Director of Endoscopic Skull Base Surgery at Mount Sinai. Endoscopic, image-guided sinus and skull base surgery — informed by ~100 peer-reviewed publications, two dedicated in-office surgical suites, and pioneering work on augmented reality and AI in the operating room.
Image-guided functional endoscopic sinus surgery (FESS), balloon sinuplasty, and biologic therapy for refractory disease. Read more →
Comprehensive medical and surgical management, including evaluation for biologic therapy in eosinophilic disease.
Endoscopic endonasal resection in collaboration with neurosurgical colleagues — pituitary adenomas, meningiomas, craniopharyngiomas.
Endoscopic repair of spontaneous and traumatic cerebrospinal fluid leaks with multilayered reconstruction. Read more →
Inverted papilloma, esthesioneuroblastoma, orbital tumors, and other malignancies of the nasal cavity and paranasal sinuses.
Workup of olfactory dysfunction with active research on neuroplasticity of the olfactory epithelium and post-COVID anosmia. Read more →
Two dedicated rooms, hospital-grade equipment, no hospital booking — many patients leave the same morning.
Real-time 3D positioning during sinus and skull base work — the same navigation used in the hospital OR.
Magnification beyond what the human eye can see, so even subtle anatomy is treated precisely.
Professional-grade suction system keeps the surgical field clear and the room sterile.
Patient-administered nitrous oxide — comfortable, fast on, fast off. No general anesthesia required for most in-office cases.
For complex skull base cases, my work in artificial intelligence and mixed reality goes from publication to operating room.
Holographic mapping of the internal carotid artery, cranial nerves, and tumor boundaries — overlaid on the live operative field during endoscopic skull base surgery.
Otolaryngology, Neurosurgery, OMFS, and Microvascular Reconstruction reference the same real-time anatomy on a unified display — eliminating verbal handoff confusion at critical moments.
First-in-field clinical study of systemic 5-aminolevulinic acid for head & neck squamous cell carcinoma — 5 of 6 patients with robust intraoperative tumor fluorescence at the margin.
Label-free real-time tissue chemistry — H&E-equivalent margin imaging in seconds versus 20–30 minutes for frozen section.
"What the team sees together determines what they can do together."From "Seeing Together" — invited lecture on team-based skull base visualization
Every visit starts with the time to actually understand what's wrong — symptoms, history, what you've already tried. Most diagnoses come from the conversation, not the scan.
Medical, surgical, in-office, hospital OR — every reasonable path is laid out with the trade-offs. You leave understanding what's available, not feeling rushed to a decision.
Endoscopic, image-guided, through the natural openings of the nose — no facial incisions, faster recovery. When appropriate, performed in-office to skip the hospital entirely.
Clear post-op instructions, recovery support, and direct access. The operation is one part — the rest is making sure your healing goes smoothly.
[ Brief bio — 1-2 sentences on Yaniz's role with patients, training, and what they handle in the practice. ]
[ Brief bio — 1-2 sentences on Alex's role and what they handle. ]
Dr. Alfred Iloreta is Co-Director of Endoscopic Skull Base Surgery at Mount Sinai Health System and Director of Rhinology and Skull Base Research. He holds a triple Assistant Professor appointment at the Icahn School of Medicine at Mount Sinai — in Otolaryngology, Neurosurgery, and Artificial Intelligence & Emerging Technology. His clinical focus is endoscopic and open surgery for paranasal sinus and skull base tumors, orbital tumors, and CSF leaks, alongside advanced therapies for inflammatory sinus disease.
As an investigator, he leads research on neurostimulation for pain and stroke, intraoperative tumor fluorescence, and the neuroplasticity of the olfactory epithelium. He is co-founder of Pharyvac Surgical Technology and a clinical collaborator at Sinai Biodesign, the institution's biotech accelerator.
Trained in Rhinology & Endoscopic Skull Base Surgery — now practicing across the country.
Year-long appointments contributing to the lab's publication pipeline and the methodological habits of surgeon-scientists.
Working with engineers and entrepreneurs in Mount Sinai's biotech accelerator on early-stage surgical device innovation.
Most advanced stage of training — where judgment and surgical philosophy are formed, not technique alone.
Two-time recipient of the Mount Sinai Department of Otolaryngology Head and Neck Surgery Teacher of the Year Award (2019, plus prior Resident Teacher of the Year, 2012–2013).
Active clinical and translational research in surgical innovation. ~100 peer-reviewed publications, primary investigator on 20+ investigator-initiated clinical trials, multiple industry-sponsored studies, and the Director of Research for the Division of Rhinology & Endoscopic Skull Base Surgery at Mount Sinai.
HoloLens overlay of carotid, cranial nerves, and tumor margins during skull base resection.
First-in-field HNSCC clinical study using systemic Gleolan®.
Label-free real-time margin imaging (Sci. Reports 2025); AI applied to operative data.
Patent-pending neuromodulation system; Pharyvac surgical aspirator (USPTO 63/037,930).
Expansile ITF mass with cavernous sinus extension; lateral skull base access required. Multi-team approach planned in a shared 3D digital twin pre-operatively — every surgeon entered the OR with the same spatial model.
Outcome. Gross total resection. Internal carotid artery preserved. Negative frozen-section margins. HoloLens holographic ICA overlay maintained spatial awareness throughout dissection.
Bilateral nasal cavity, orbit, maxilla, ITF, and middle cranial fossa involvement. Coordinated approach across Rhinology, Neurosurgery, OMFS, and Microvascular Reconstruction.
Outcome. R0 negative-margin resection. Orbit preserved. No vascular injury. Mixed reality and 3D modeling enabled a morbidity-minimizing transmaxillary corridor that avoided mandibular osteotomy and parotid translocation.
Endoscopic resection of a nasal dermoid in a young child. Co-surgeon Dr. Aldo Londino. ~6 minutes.
Watch on YouTube →Endoscopic resection of a vascular nasopharyngeal angiofibroma — the locally aggressive but benign tumor of the adolescent male nasopharynx.
Watch on Vimeo →Postoperative endoscopic survey of the same case — clean surgical bed, intact landmarks, no residual disease.
Watch on Vimeo →Use of the SonoPet ultrasonic aspirator for precise sinonasal bone work — controlled tissue removal with preserved hemostasis.
Watch on Vimeo →A foundational framework for using AI, computer vision, and neural networks to connect patient data, surgical methodology, and outcomes.
Video coming soonFirst-in-field clinical study of systemic 5-aminolevulinic acid for HNSCC — five of six patients with robust intraoperative tumor fluorescence at the margin.
Video coming soonTalk delivered at Virtual Medicine 2022 — practical experience overlaying carotid, cranial nerves, and tumor boundaries onto the live operative field during endoscopic skull base resection.
Watch on YouTube →Clinical practice page
Full scholarly record
Papers and metrics
Papers and citations
Career & ventures
Verified credentials
NY Metro selection
Booking & ratings